Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1202888010 | Prednisolone acetate + sulfacetamide sodium 5mg/100mg suspension (product) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 1478910014 | Prednisolone acetate+sulfacetamide sodium 5mg/100mg suspension | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 2871169017 | Prednisolone acetate + sulphacetamide sodium 5mg/100mg suspension | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3269961000052112 | prednisolonacetat 5 mg + natriumsulfacetamid 100 mg, suspension | sv | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Sweden NRC maintained module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| prednisolonacetat 5 mg + natriumsulfacetamid 100 mg, suspension | Is a | Product containing prednisolone (medicinal product) | false | Inferred relationship | Some | ||
| prednisolonacetat 5 mg + natriumsulfacetamid 100 mg, suspension | Is a | Product containing sulfacetamide (medicinal product) | false | Inferred relationship | Some | ||
| prednisolonacetat 5 mg + natriumsulfacetamid 100 mg, suspension | Is a | Product containing prednisolone in ocular dose form (medicinal product form) | false | Inferred relationship | Some | ||
| prednisolonacetat 5 mg + natriumsulfacetamid 100 mg, suspension | Is a | sulfonamidpreparat för oftalmiskt bruk | false | Inferred relationship | Some | ||
| prednisolonacetat 5 mg + natriumsulfacetamid 100 mg, suspension | Has active ingredient | Sulfacetamide (substance) | false | Inferred relationship | Some | ||
| prednisolonacetat 5 mg + natriumsulfacetamid 100 mg, suspension | Has active ingredient | Prednisolone ophthalmic preparation | false | Inferred relationship | Some | ||
| prednisolonacetat 5 mg + natriumsulfacetamid 100 mg, suspension | Has active ingredient | Sulfonamide (substance) | false | Inferred relationship | Some | ||
| prednisolonacetat 5 mg + natriumsulfacetamid 100 mg, suspension | Has active ingredient | Sulfacetamide sodium | false | Inferred relationship | Some | ||
| prednisolonacetat 5 mg + natriumsulfacetamid 100 mg, suspension | Has active ingredient | Corticosterone | false | Inferred relationship | Some | ||
| prednisolonacetat 5 mg + natriumsulfacetamid 100 mg, suspension | Has active ingredient | Prednisolone acetate | false | Inferred relationship | Some | ||
| prednisolonacetat 5 mg + natriumsulfacetamid 100 mg, suspension | Is a | prednisolonacetat + natriumsulfacetamid | false | Inferred relationship | Some | ||
| prednisolonacetat 5 mg + natriumsulfacetamid 100 mg, suspension | Has active ingredient | binjurehormonmedel | false | Inferred relationship | Some | ||
| prednisolonacetat 5 mg + natriumsulfacetamid 100 mg, suspension | Has active ingredient | Bactericide | false | Inferred relationship | Some | ||
| prednisolonacetat 5 mg + natriumsulfacetamid 100 mg, suspension | Has active ingredient | Glucocorticoid hormone | false | Inferred relationship | Some | ||
| prednisolonacetat 5 mg + natriumsulfacetamid 100 mg, suspension | Has manufactured dose form | Ocular dose form (dose form) | false | Inferred relationship | Some | ||
| prednisolonacetat 5 mg + natriumsulfacetamid 100 mg, suspension | Has manufactured dose form | läkemedelssuspension | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Concept inactivation indicator reference set
FHIR